Front Page

Previous Story

Next Story

NIH Record vertical blue bar column separator

Medicine for the Public Lecture Series

The Medicine for the Public lecture series, now in its 25th year, features physician-scientists working at the frontiers of medical research at NIH. The series helps people understand the latest developments in medicine — new therapies, diagnostic procedures and research. The emphasis is on current topics, with speakers who can relate to the lay public.

Sponsored by the Clinical Center, the lectures are held at 7 p.m. on Tuesdays in the Clinical Center's Masur Auditorium.

The lectures began on Sept. 25 and include:

Oct. 2 — The Sexually Transmitted Disease Epidemic: A Threat to the Nation's Public Health

Every year, about 12 million people acquire sexually transmitted diseases. These diseases lead to multiple complications, including infertility, ectopic pregnancies, chronic pain and cancer. Most cases can be cured. All of them can be prevented. Dr. Thomas Quinn, chief, international HIV/AIDS and STDs section, Laboratory of Immunoregulation, NIAID, will discuss the incidence, the costs, the impact on society and what can be done to decrease the risk of sexually transmitted diseases.

Oct. 9 — New Strategies for the Detection and Treatment of Colon Cancer

Colon cancer strikes 130,000 people a year. It is the second leading cause of cancer death in the United States and has a mortality rate of nearly 50 percent. Dr. Steven Libutti, senior investigator, Surgery Branch, NCI, will discuss how it is detected and treated. He will also discuss what new detection and treatment options are currently under study to increase survival, including local ablative therapy, anti-angiogenic therapy and new ways to deliver chemotherapy.

Oct. 16 — Breast Cancer: Progress and Promise

Dr. Jo Anne Zujewski, senior medical oncologist, Center for Cancer Research, NCI, will discuss the risk factors for developing breast cancer and current treatment options. She will review progress made in this disease and look at promising new research directions.

Oct. 23 — Type 1 Diabetes: A Quest for Better Therapies

Sixteen million people in the U.S. have diabetes; 1 million of them have type 1. It is the sixth leading cause of death in this country and often leads to blindness, heart and blood vessel disease, strokes, kidney failure, amputations and nerve damage. Dr. David Harlan, chief, Transplantation and Autoimmunity Branch, NIDDK, will discuss the difference between type 1 and type 2 diabetes, then will focus on advances in how physicians might treat type 1 diabetes.

Oct. 30 — The Influenza Viruses and Their Vaccines

About 10 to 20 percent of Americans are infected with the influenza virus each year. For most, the aches and pains associated with the flu come and go within a couple of weeks. However, an estimated 100,000 people are hospitalized, and 20,000 deaths occur annually from the flu and its complications. Dr. Brian Murphy, co-chief, Laboratory of Infectious Diseases, NIAID, will explore the latest findings in flu vaccines, including a new influenza virus vaccine undergoing evaluation by the Food and Drug Administration.

For details on the series, call 496-2563, or visit http://www.cc.nih.gov/ccc/mfp/series.html.


Up to Top